14.01.2022 Geratherm Medical AG  DE0005495626

DGAP-Adhoc: Geratherm Medical AG: Medical heating blankets for clinical surgery


 

DGAP-Ad-hoc: Geratherm Medical AG / Key word(s): Miscellaneous
Geratherm Medical AG: Medical heating blankets for clinical surgery

14-Jan-2022 / 14:29 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of an insider information pursuant to article 17 of MAR
transmitted by DGAP - a service of EQS Group AG

Medical heating blankets for clinical surgery

Geratal, January 14, 2022. Today, Geratherm Medical AG (ISIN: DE0005495626) decided, in agreement between the Supervisory Board and Management Board, to discontinue the area of medical heating blankets for clinical surgery and the associated research and development with immediate effect. The current market situation and market prospects for the product do not reflect the associated expenses for certification according to MDR.

As of December 31, 2021, there will be a special depreciation of around EUR 900 thousand, which will be offset by annual savings, especially for R&D expenses and certifications, of around EUR 400 thousand. There are no notable declines in sales in this area due to recertification.

With this measure, the company sees itself in a stronger position for the future.

Geratherm Medical AG
Firmensitz: Fahrenheitstraße 1, 99331 Geratal
Registergericht: Amtsgericht Jena, HRB 111272
Vorstand: Christian Frick
Aufsichtsratsvorsitzender: Dr. Gert Frank
Tel. 036205/98 0; Fax: 036205/98 115
E-Mail: [email protected]
www.geratherm.com


Short company profil:
Geratherm Medical is an internationally operating medical products enterprise with the business areas Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services and MR Diagnostic Incubator Systems for premature babies and newborns. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function. In all mainly business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data. Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Healthcare Index.

 

 




Contact:
Christian Frick

14-Jan-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
99331 Geratal
Germany
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: [email protected]
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1269020

 
End of Announcement DGAP News Service

1269020  14-Jan-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1269020&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023
Umsatzerlöse1 21,03 21,52 19,85 27,47 23,94 25,85 20,96
EBITDA1,2 1,77 2,80 2,35 4,35 2,31 3,55 4,27
EBITDA-Marge3 8,42 13,01 11,84 15,84 9,65 13,73
EBIT1,4 0,63 1,99 1,05 3,04 0,59 2,07 2,55
EBIT-Marge5 3,00 9,25 5,29 11,07 2,46 8,01 12,17
Jahresüberschuss1 0,22 0,83 0,29 1,90 0,33 1,08 1,67
Netto-Marge6 1,05 3,86 1,46 6,92 1,38 4,18 7,97
Cashflow1,7 2,47 1,35 1,54 3,92 0,92 2,79 1,47
Ergebnis je Aktie8 0,14 0,23 0,11 0,41 0,02 0,19 0,21
Dividende8 0,47 0,40 0,25 0,40 0,12 0,15 0,50
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Baker Tilly

INVESTOR-INFORMATIONEN
©boersengefluester.de
Geratherm Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
549562 3,000 Verkaufen 16,24
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
14,29 27,16 0,57 14,93
KBV KCV KUV EV/EBITDA
0,75 11,03 0,77 3,68
Dividende '22 in € Dividende '23 in € Div.-Rendite '23
in %
Hauptversammlung
0,15 0,10 3,33 16.08.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
- 15.08.2024 - 20.06.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-25,47% -30,35% -44,44% -45,45%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Geratherm Medical AG  ISIN: DE0005495626 können Sie bei EQS abrufen


Medtech , 549562 , GME , XETR:GME